Cytogenetic damage in workers exposed to ethylene oxide. 1984

F Sarto, and I Cominato, and A M Pinton, and P G Brovedani, and C M Faccioli, and V Bianchi, and A G Levis

Sister-chromatid exchanges (SECs) and chromosomal aberrations (CAs) were detected in the peripheral lymphocytes of 41 sanitary workers exposed to ethylene oxide (EO) in the sterilizing units of 8 hospitals in the Venice Region. The first group (19 workers) was exposed to 10.7 +/- 4.9 ppm EO, expressed as the time-weighted average concentration for an 8-h working day (TWA/8 h conc.), and the second group (22 workers) to 0.35 +/- 0.12 ppm. Each exposed worker was paired with a control of similar age and smoking habits. A highly significant (P less than 0.001) increase in the mean frequency of SCEs was found in the higher exposure group, 14 (74%) exposed subjects having significantly increased levels of SCEs compared to their matched controls. In the lower exposure group, the increase in mean frequency of SCEs was lower, though still significant (P less than 0.05): 7 (33%) exposed subjects had higher and 1 (5%) had a lower SCE level than the matched controls. From the first group, 10 subjects, 7 of whom had increased SCE levels, were reanalysed 12-18 months after their exposure had been lowered or interrupted: in only 2 of them the SCE level was significantly decreased. A statistically significant correlation between SCE frequency and level of EO exposure (TWA/8 h conc.), as well as a multiple correlation between SCE level and EO exposure, smoking and age were found. However, no interaction could be detected between EO exposure and smoking in the induction of SCEs. In controls, SCE frequency was correlated with smoking and age. In the higher exposure group, the number of both chromatid- and chromosome-type aberrations, independent of gaps, was significantly increased, whereas in the lower exposure group only the frequency of chromosome-type aberrations, excluding gaps, was statistically higher than in controls. The level of CAs remained to a great extent unchanged in the 10 subjects re-examined at a later stage after lowering or halting exposure. Taking the group as a whole, the frequency of cells with total CAs was found to be weakly (P = 0.05) correlated with EO exposure, and was not correlated with smoking, age or SCE frequency.

UI MeSH Term Description Entries
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008677 Metaphase The phase of cell nucleus division following PROMETAPHASE, in which the CHROMOSOMES line up across the equatorial plane of the SPINDLE APPARATUS prior to separation.
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010564 Personnel, Hospital The individuals employed by the hospital. Hospital Personnel
D002495 Central Supply, Hospital Hospital department responsible for receiving, storing, and distributing medical and surgical supplies and equipment. Hospital Central Supplies,Hospital Central Supply,Supplies, Hospital Central,Supply, Hospital Central,Central Supplies, Hospital
D002869 Chromosome Aberrations Abnormal number or structure of chromosomes. Chromosome aberrations may result in CHROMOSOME DISORDERS. Autosome Abnormalities,Cytogenetic Aberrations,Abnormalities, Autosome,Abnormalities, Chromosomal,Abnormalities, Chromosome,Chromosomal Aberrations,Chromosome Abnormalities,Cytogenetic Abnormalities,Aberration, Chromosomal,Aberration, Chromosome,Aberration, Cytogenetic,Aberrations, Chromosomal,Aberrations, Chromosome,Aberrations, Cytogenetic,Abnormalities, Cytogenetic,Abnormality, Autosome,Abnormality, Chromosomal,Abnormality, Chromosome,Abnormality, Cytogenetic,Autosome Abnormality,Chromosomal Aberration,Chromosomal Abnormalities,Chromosomal Abnormality,Chromosome Aberration,Chromosome Abnormality,Cytogenetic Aberration,Cytogenetic Abnormality
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005027 Ethylene Oxide A colorless and flammable gas at room temperature and pressure. Ethylene oxide is a bactericidal, fungicidal, and sporicidal disinfectant. It is effective against most micro-organisms, including viruses. It is used as a fumigant for foodstuffs and textiles and as an agent for the gaseous sterilization of heat-labile pharmaceutical and surgical materials. (From Reynolds, Martindale The Extra Pharmacopoeia, 30th ed, p794) Oxirane,Oxide, Ethylene
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

F Sarto, and I Cominato, and A M Pinton, and P G Brovedani, and C M Faccioli, and V Bianchi, and A G Levis
January 1987, Journal of hygiene, epidemiology, microbiology, and immunology,
F Sarto, and I Cominato, and A M Pinton, and P G Brovedani, and C M Faccioli, and V Bianchi, and A G Levis
January 1992, Israel journal of medical sciences,
F Sarto, and I Cominato, and A M Pinton, and P G Brovedani, and C M Faccioli, and V Bianchi, and A G Levis
March 1979, JAMA,
F Sarto, and I Cominato, and A M Pinton, and P G Brovedani, and C M Faccioli, and V Bianchi, and A G Levis
October 1991, The New England journal of medicine,
F Sarto, and I Cominato, and A M Pinton, and P G Brovedani, and C M Faccioli, and V Bianchi, and A G Levis
May 1991, The New England journal of medicine,
F Sarto, and I Cominato, and A M Pinton, and P G Brovedani, and C M Faccioli, and V Bianchi, and A G Levis
January 1992, Mutation research,
F Sarto, and I Cominato, and A M Pinton, and P G Brovedani, and C M Faccioli, and V Bianchi, and A G Levis
June 1986, Mutation research,
F Sarto, and I Cominato, and A M Pinton, and P G Brovedani, and C M Faccioli, and V Bianchi, and A G Levis
November 2010, Mutagenesis,
F Sarto, and I Cominato, and A M Pinton, and P G Brovedani, and C M Faccioli, and V Bianchi, and A G Levis
June 2008, Environmental and molecular mutagenesis,
F Sarto, and I Cominato, and A M Pinton, and P G Brovedani, and C M Faccioli, and V Bianchi, and A G Levis
January 2001, Cytobios,
Copied contents to your clipboard!